PHARMACEUTICAL COMPOSITION COMPRISNG A SGLT2 INHIBITOR, A DPP-IV INHIBITOR AND OPTIONALLY A FURTHER ANTIDIABETIC AGENT AND USES THEREOF

PHARMACEUTICAL COMPOSITION COMPRISNG A SGLT2 INHIBITOR, A DPP-IV INHIBITOR AND OPTIONALLY A FURTHER ANTIDIABETIC AGENT AND USES THEREOF

The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BROEDL, ULI, GREMPLER, ROLF, EICKELMANN, PETER, THOMAS, LEO, MARK, MICHAEL, SEMAN, LEO, JOHN
Format: Patent
Sprache:eng ; srp
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BROEDL, ULI
GREMPLER, ROLF
EICKELMANN, PETER
THOMAS, LEO
MARK, MICHAEL
SEMAN, LEO, JOHN
description The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RS60438B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RS60438B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RS60438B13</originalsourceid><addsrcrecordid>eNqFjUEKwjAURLtxIeoV5B_AgloRt79p2nxok5D8Cq5KkbgSLdQ7eG3bIrh0NcPMG2Yeva1CV6GQNZPAEoSprPHEZPTkHXldAIIvSt4DaUUpsXGbIcqsjen8ywB1BsaOUyzLy0DktWMlx4IpI0zl8AFYSM0TW3vpYQSkyZfR7Nbe-7D66iJa55KFikP3bELftdfwCK_G-eP2kJzSXfIX-ACmmzzQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITION COMPRISNG A SGLT2 INHIBITOR, A DPP-IV INHIBITOR AND OPTIONALLY A FURTHER ANTIDIABETIC AGENT AND USES THEREOF</title><source>esp@cenet</source><creator>BROEDL, ULI ; GREMPLER, ROLF ; EICKELMANN, PETER ; THOMAS, LEO ; MARK, MICHAEL ; SEMAN, LEO, JOHN</creator><creatorcontrib>BROEDL, ULI ; GREMPLER, ROLF ; EICKELMANN, PETER ; THOMAS, LEO ; MARK, MICHAEL ; SEMAN, LEO, JOHN</creatorcontrib><description>The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.</description><language>eng ; srp</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200731&amp;DB=EPODOC&amp;CC=RS&amp;NR=60438B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200731&amp;DB=EPODOC&amp;CC=RS&amp;NR=60438B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BROEDL, ULI</creatorcontrib><creatorcontrib>GREMPLER, ROLF</creatorcontrib><creatorcontrib>EICKELMANN, PETER</creatorcontrib><creatorcontrib>THOMAS, LEO</creatorcontrib><creatorcontrib>MARK, MICHAEL</creatorcontrib><creatorcontrib>SEMAN, LEO, JOHN</creatorcontrib><title>PHARMACEUTICAL COMPOSITION COMPRISNG A SGLT2 INHIBITOR, A DPP-IV INHIBITOR AND OPTIONALLY A FURTHER ANTIDIABETIC AGENT AND USES THEREOF</title><description>The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjUEKwjAURLtxIeoV5B_AgloRt79p2nxok5D8Cq5KkbgSLdQ7eG3bIrh0NcPMG2Yeva1CV6GQNZPAEoSprPHEZPTkHXldAIIvSt4DaUUpsXGbIcqsjen8ywB1BsaOUyzLy0DktWMlx4IpI0zl8AFYSM0TW3vpYQSkyZfR7Nbe-7D66iJa55KFikP3bELftdfwCK_G-eP2kJzSXfIX-ACmmzzQ</recordid><startdate>20200731</startdate><enddate>20200731</enddate><creator>BROEDL, ULI</creator><creator>GREMPLER, ROLF</creator><creator>EICKELMANN, PETER</creator><creator>THOMAS, LEO</creator><creator>MARK, MICHAEL</creator><creator>SEMAN, LEO, JOHN</creator><scope>EVB</scope></search><sort><creationdate>20200731</creationdate><title>PHARMACEUTICAL COMPOSITION COMPRISNG A SGLT2 INHIBITOR, A DPP-IV INHIBITOR AND OPTIONALLY A FURTHER ANTIDIABETIC AGENT AND USES THEREOF</title><author>BROEDL, ULI ; GREMPLER, ROLF ; EICKELMANN, PETER ; THOMAS, LEO ; MARK, MICHAEL ; SEMAN, LEO, JOHN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RS60438B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; srp</language><creationdate>2020</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BROEDL, ULI</creatorcontrib><creatorcontrib>GREMPLER, ROLF</creatorcontrib><creatorcontrib>EICKELMANN, PETER</creatorcontrib><creatorcontrib>THOMAS, LEO</creatorcontrib><creatorcontrib>MARK, MICHAEL</creatorcontrib><creatorcontrib>SEMAN, LEO, JOHN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BROEDL, ULI</au><au>GREMPLER, ROLF</au><au>EICKELMANN, PETER</au><au>THOMAS, LEO</au><au>MARK, MICHAEL</au><au>SEMAN, LEO, JOHN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITION COMPRISNG A SGLT2 INHIBITOR, A DPP-IV INHIBITOR AND OPTIONALLY A FURTHER ANTIDIABETIC AGENT AND USES THEREOF</title><date>2020-07-31</date><risdate>2020</risdate><abstract>The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; srp
recordid cdi_epo_espacenet_RS60438B1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PHARMACEUTICAL COMPOSITION COMPRISNG A SGLT2 INHIBITOR, A DPP-IV INHIBITOR AND OPTIONALLY A FURTHER ANTIDIABETIC AGENT AND USES THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T06%3A14%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BROEDL,%20ULI&rft.date=2020-07-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERS60438B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true